KIR3DL1 and neuroblastoma: Longer-term (24 h) live-imaging killing assays confirmed that KIR+ UCB56NK cells had equivalent cytotoxicity against the three neuroblastoma lines, consistent with the results obtained with 721.221 cells (Supplementary Figure 3C).